ST. LOUIS, Oct. 8, 2012 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) today unveiled two Medicare Part D plans through its Express Scripts Medicare™ Prescription Drug Plan (PDP), formerly Medco ...
ST. LOUIS, Oct. 11 /PRNewswire/ -- Through a set of proprietary computer models, Express Scripts, Inc. (Nasdaq: ESRX), is now able to accurately predict up to a year in advance which patients are most ...
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna Corporation (NYSE: CI) (“Cigna”) today announced that Cigna shareholders have voted, at a special meeting of shareholders held earlier today, to approve the ...
BLOOMFIELD, Conn.--(BUSINESS WIRE)--Cigna Corporation (NYSE: CI), a leading global health service company, has successfully completed its combination with Express Scripts Holding Company (“Express ...
ST. LOUIS, March 14, 2011 /PRNewswire/ -- Members served by Express Scripts (Nasdaq: ESRX) can now access their pharmacy benefits account on their smart phones using ...
ST. LOUIS, Oct. 30, 2012 /PRNewswire/ -- Prescription-drug treatment regimens for conditions that are a normal part of aging are now costing the nation more than many serious and potentially ...
Rebecca Rabbitt spoke about Navigating Medicare and Healthcare Reform. Express Scripts is offering a free eGuide for seniors with information about healthcare reform and its impact on Medicare, as ...
The impact on TRICARE of a new retail pharmacy agreement between Express Scripts, Inc., (ESI) and Walgreens pharmacy has not yet been determined. [Editor's Note: Read ESI and Walgreens official ...
ST. LOUIS, April 20 /PRNewswire-FirstCall/ -- In the midst of the financial crisis and skyrocketing healthcare costs, greater use of generic drugs and lower-cost ...
Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...
Express Scripts' (ESRX) plan to lay off nearly 1,000 workers at its Bensalem, Penn., facility looks like one of those unfortunate "synergies" management likes to talk about following an acquisition.
Substantial savings opportunity as $39.5 billion in popular brand name drugs will have generic equivalents for the first time in 2012 and 2013 ST. LOUIS, Oct. 8, 2012 /PRNewswire/ -- Express Scripts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback